{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T18:07:17Z","timestamp":1790273237336,"version":"4.1.0"},"reference-count":36,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T00:00:00Z","timestamp":1790208000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001840","name":"Icelandic Centre for Research","doi-asserted-by":"publisher","award":["2422636-602"],"award-info":[{"award-number":["2422636-602"]}],"id":[{"id":"10.13039\/501100001840","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:p>\n                    Ventilator-induced lung injury (VILI) is a significant complication of mechanical ventilation, contributing to morbidity and mortality in critically ill patients. Excessive mechanical stress triggers an inflammatory cascade, leading to lung damage, pulmonary oedema, and systemic complications. While macrolide antibiotics such as azithromycin (AZM) have demonstrated anti-inflammatory and epithelial barrier strengthening effects, their use is limited by concerns regarding antibiotic resistance. EP317, an azithromycin-derived compound with negligible antibacterial activity, was designed to retain the immunomodulatory and epithelial barrier enhancing effects of AZM while mitigating the risk of bacterial resistance. This study investigated the effects of AZM and EP317 in a rat model of VILI. Forty-eight rats were divided into six groups (N\u2009=\u20098 per group), receiving either placebo, AZM, or EP317 (5 mg\/kg daily for seven days), with half of the animals subjected to mechanical ventilation with peak airway pressure at 35 cmH\n                    <jats:sub>2<\/jats:sub>\n                    O. Both compounds attenuated ventilation-induced pulmonary oedema, reflected in a smaller increase in lung wet\/dry ratio, whereas ventilation-induced increases in total protein in bronchoalveolar lavage fluid (BALF) were not significantly reduced by either treatment. Cytokine profiling in plasma (L-Selectin, PAI-1, RANTES, MCP-3, IL-6, SCF, IL-17a, RAGE, MIP-3\u03b1, IL-13, G-CSF, IL-10, M-CSF, IFN-\u03b3, GRO-KC and MMP9) revealed that both treatments attenuated inflammatory responses, while cytokine levels in BALF in ventilated animals were either unchanged or increased. Survival rates were improved in the treatment groups. Histological analysis indicated increased oedema in ventilated animals, likely due to the high-pressure ventilation, while drug-treated groups exhibited reduced oedema. Global gene expression profiling by RNA sequencing revealed robust upregulation of inflammatory and stress-response pathways in ventilated animals, with partial attenuation following AZM or EP317 pre-treatment. These findings suggest that EP317 and AZM offer protective effects against VILI. EP317 presents a promising alternative to conventional macrolide therapy by circumventing antibiotic resistance concerns.\n                  <\/jats:p>","DOI":"10.1371\/journal.pone.0358745","type":"journal-article","created":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T17:25:46Z","timestamp":1790270746000},"page":"e0358745","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":0,"title":["Azithromycin and its non-antibacterial derivative EP317 attenuate select aspects of ventilator-induced lung injury in rats"],"prefix":"10.1371","volume":"21","author":[{"given":"Sigurbergur","family":"Karason","sequence":"first","affiliation":[{"name":"Landspitali-University Hospital","place":["Reykjavik, Iceland"],"department":["Department of Anaesthesia and Intensive Care"]},{"name":"University of Iceland","place":["Reykjavik, Iceland"],"department":["Stem Cell Research Unit, BioMedical Centre, School of Health Sciences"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-1818-567X","authenticated-orcid":true,"given":"Arni","family":"Asbjarnarson","sequence":"additional","affiliation":[{"name":"University of Iceland","place":["Reykjavik, Iceland"],"department":["Stem Cell Research Unit, BioMedical Centre, School of Health Sciences"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saevar","family":"Ingthorsson","sequence":"additional","affiliation":[{"name":"University of Iceland","place":["Reykjavik, Iceland"],"department":["Faculty of Nursing and Midwifery"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kolbrun Bjork","family":"Jonasdottir","sequence":"additional","affiliation":[{"name":"University of Iceland","place":["Reykjavik, Iceland"],"department":["Stem Cell Research Unit, BioMedical Centre, School of Health Sciences"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Kricker","sequence":"additional","affiliation":[{"name":"EpiEndo Pharmaceuticals","place":["Reykjavik, Iceland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thorarinn","family":"Gudjonsson","sequence":"additional","affiliation":[{"name":"University of Iceland","place":["Reykjavik, Iceland"],"department":["Stem Cell Research Unit, BioMedical Centre, School of Health Sciences"]},{"name":"Landspitali-University Hospital","place":["Reykjavik, Iceland"],"department":["Department of Laboratory Hematology"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3261-4504","authenticated-orcid":true,"given":"Jon Petur","family":"Joelsson","sequence":"additional","affiliation":[{"name":"University of Iceland","place":["Reykjavik, Iceland"],"department":["Stem Cell Research Unit, BioMedical Centre, School of Health Sciences"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2026,9,24]]},"reference":[{"issue":"22","key":"pone.0358745.ref001","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1056\/NEJMra1208707","article-title":"Ventilator-induced lung injury","volume":"369","author":"AS Slutsky","year":"2013","journal-title":"N Engl J Med"},{"issue":"5","key":"pone.0358745.ref002","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.3390\/ijms26052287","article-title":"The non-antibacterial effects of azithromycin and other macrolides on the bronchial epithelial barrier and cellular differentiation","volume":"26","author":"A Asbjarnarson","year":"2025","journal-title":"Int J Mol Sci"},{"issue":"1","key":"pone.0358745.ref003","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/1465-9921-14-52","article-title":"Anti-inflammatory effects of clarithromycin in ventilator-induced lung injury","volume":"14","author":"L Amado-Rodr\u00edguez","year":"2013","journal-title":"Respir Res"},{"issue":"8","key":"pone.0358745.ref004","doi-asserted-by":"crossref","first-page":"3883","DOI":"10.1128\/AAC.00457-13","article-title":"Azithromycin attenuates lung inflammation in a mouse model of ventilator-associated pneumonia by multidrug-resistant Acinetobacter baumannii","volume":"57","author":"K Yamada","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"pone.0358745.ref005","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s42826-022-00133-4","article-title":"Ventilator-induced lung injury results in oxidative stress response and mitochondrial swelling in a mouse model","volume":"38","author":"JP Joelsson","year":"2022","journal-title":"Lab Anim Res"},{"issue":"1","key":"pone.0358745.ref006","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1186\/s40064-016-2866-1","article-title":"Efficacy of azithromycin in sepsis-associated acute respiratory distress syndrome: A retrospective study and propensity score analysis","volume":"5","author":"K Kawamura","year":"2016","journal-title":"Springerplus"},{"key":"pone.0358745.ref007","unstructured":"Agency EM. Changes to the use of antibiotic azithromycin European Medicines Agency: European Medicines Agency; 2025. Available from: https:\/\/www.ema.europa.eu\/en\/news\/changes-use-antibiotic-azithromycin"},{"issue":"1","key":"pone.0358745.ref008","doi-asserted-by":"crossref","first-page":"237","DOI":"10.3390\/biomedicines14010237","article-title":"In vitro and in vivo efficacy of epithelial barrier-promoting barriolides as potential therapy for ulcerative colitis","volume":"14","author":"JP Joelsson","year":"2026","journal-title":"Biomedicines"},{"key":"pone.0358745.ref009","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.curtheres.2003.09.004","article-title":"Single-dose azithromycin for acute otitis media: A pharmacokinetic\/pharmacodynamic rationale","volume":"64","author":"CD Rothermel","year":"2003","journal-title":"Curr Ther Res Clin Exp"},{"key":"pone.0358745.ref010","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1093\/jac\/25.suppl_A.49","article-title":"Pharmacokinetics of azithromycin in rats and dogs","author":"RM Shepard","year":"1990","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"pone.0358745.ref011","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s42826-025-00240-y","article-title":"Ventilator-induced lung injury in rat models: Are they all equal in the race?","volume":"41","author":"JP Joelsson","year":"2025","journal-title":"Lab Anim Res"},{"issue":"3","key":"pone.0358745.ref012","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/ng1180","article-title":"PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes","volume":"34","author":"VK Mootha","year":"2003","journal-title":"Nat Genet"},{"issue":"43","key":"pone.0358745.ref013","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"A Subramanian","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"pone.0358745.ref014","doi-asserted-by":"crossref","first-page":"1229463","DOI":"10.3389\/fmed.2023.1229463","article-title":"Systemic and functional effects of continuous azithromycin treatment in patients with severe chronic obstructive pulmonary disease and frequent exacerbations","volume":"10","author":"E Cuevas","year":"2023","journal-title":"Front Med (Lausanne)"},{"issue":"3","key":"pone.0358745.ref015","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.resp.2007.05.010","article-title":"Alveolar edema fluid clearance and acute lung injury","volume":"159","author":"Y Berthiaume","year":"2007","journal-title":"Respir Physiol Neurobiol"},{"key":"pone.0358745.ref016","article-title":"Static Stretch Increases the Pro-Inflammatory Response of Rat Type 2 Alveolar Epithelial Cells to Dynamic Stretch","volume":"13","author":"JMC Ferreira","year":"2022","journal-title":"Front Physiol"},{"key":"pone.0358745.ref017","doi-asserted-by":"crossref","first-page":"293","DOI":"10.2119\/molmed.2010.00138","article-title":"Contribution of neutrophils to acute lung injury","volume":"17","author":"J Grommes","year":"2011","journal-title":"Mol Med"},{"issue":"9","key":"pone.0358745.ref018","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.4187\/respcare.02992","article-title":"Spillover of cytokines and reactive oxygen species in ventilator-induced lung injury associated with inflammation and apoptosis in distal organs","volume":"59","author":"Y-Y Liu","year":"2014","journal-title":"Respiratory Care"},{"key":"pone.0358745.ref019","doi-asserted-by":"crossref","first-page":"966060","DOI":"10.3389\/fonc.2023.966060","article-title":"Immunomodulatory role of azithromycin: Potential applications to radiation-induced lung injury","volume":"13","author":"Y Yan","year":"2023","journal-title":"Front Oncol"},{"issue":"6","key":"pone.0358745.ref020","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/S2213-2600(20)30080-1","article-title":"Immunomodulation by macrolides: Therapeutic potential for critical care","volume":"8","author":"TDY Reijnders","year":"2020","journal-title":"Lancet Respir Med"},{"issue":"23","key":"pone.0358745.ref021","doi-asserted-by":"crossref","first-page":"5374","DOI":"10.12998\/wjcc.v12.i23.5374","article-title":"Impact of interleukin 6 levels on acute lung injury risk and disease severity in critically ill sepsis patients","volume":"12","author":"Y Liu","year":"2024","journal-title":"World J Clin Cases"},{"issue":"1","key":"pone.0358745.ref022","doi-asserted-by":"crossref","first-page":"205","DOI":"10.3390\/ijms24010205","article-title":"The Potential Importance of CXCL1 in the Physiological State and in Noncancer Diseases of the Cardiovascular System, Respiratory System and Skin","volume":"24","author":"J Korbecki","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"6","key":"pone.0358745.ref023","doi-asserted-by":"crossref","DOI":"10.1152\/ajprenal.00025.2012","article-title":"Circulating IL-6 mediates lung injury via CXCL1 production after acute kidney injury in mice","volume":"303","author":"N Ahuja","year":"2012","journal-title":"Am J Physiol Renal Physiol"},{"issue":"3","key":"pone.0358745.ref024","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.4049\/jimmunol.181.3.2189","article-title":"IL-6 regulates neutrophil trafficking during acute inflammation via STAT3","volume":"181","author":"CA Fielding","year":"2008","journal-title":"J Immunol"},{"key":"pone.0358745.ref025","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.768813","article-title":"Neutrophil-Derived IL-17 Promotes Ventilator-Induced Lung Injury via p38 MAPK\/MCP-1 Pathway Activation","volume":"12","author":"X Liao","year":"2021","journal-title":"Front Immunol"},{"key":"pone.0358745.ref026","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.953195","article-title":"The role of neutrophil extracellular traps in acute lung injury","volume":"13","author":"D Scozzi","year":"2022","journal-title":"Front Immunol"},{"issue":"7","key":"pone.0358745.ref027","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1002\/bdd.767","article-title":"Distribution characteristics of clarithromycin and azithromycin, macrolide antimicrobial agents used for treatment of respiratory infections, in lung epithelial lining fluid and alveolar macrophages","volume":"32","author":"K Togami","year":"2011","journal-title":"Biopharm Drug Dispos"},{"issue":"11","key":"pone.0358745.ref028","doi-asserted-by":"crossref","first-page":"2582","DOI":"10.1128\/AAC.40.11.2582","article-title":"Intrapulmonary pharmacokinetics of azithromycin in healthy volunteers given five oral doses","volume":"40","author":"KM Olsen","year":"1996","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"pone.0358745.ref029","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1128\/AAC.41.6.1399","article-title":"Intrapulmonary steady-state concentrations of clarithromycin and azithromycin in healthy adult volunteers","volume":"41","author":"KA Rodvold","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"pone.0358745.ref030","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1001\/jama.282.1.54","article-title":"Effect of mechanical ventilation on inflammatory mediators in patients with acute respiratory distress syndrome: A randomized controlled trial","volume":"282","author":"VM Ranieri","year":"1999","journal-title":"JAMA"},{"issue":"10","key":"pone.0358745.ref031","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1007\/s00134-004-2363-9","article-title":"Ventilator-induced lung injury and multiple system organ failure: A critical review of facts and hypotheses","volume":"30","author":"FB Pl\u00f6tz","year":"2004","journal-title":"Intensive Care Med"},{"issue":"3","key":"pone.0358745.ref032","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1128\/CMR.00078-09","article-title":"Mechanisms of action and clinical application of macrolides as immunomodulatory medications","volume":"23","author":"S Kanoh","year":"2010","journal-title":"Clin Microbiol Rev"},{"issue":"1","key":"pone.0358745.ref033","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/s41392-025-02127-9","article-title":"Advances in acute respiratory distress syndrome: focusing on heterogeneity, pathophysiology, and therapeutic strategies","volume":"10","author":"W Ma","year":"2025","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"pone.0358745.ref034","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/s41392-025-02178-y","article-title":"Deep insight into cytokine storm: From pathogenesis to treatment","volume":"10","author":"J Nie","year":"2025","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"pone.0358745.ref035","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1152\/physiolgenomics.00110.2005","article-title":"Gene expression profiling of target genes in ventilator-induced lung injury","volume":"26","author":"T Dolinay","year":"2006","journal-title":"Physiol Genomics"},{"issue":"4","key":"pone.0358745.ref036","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1124\/pharmrev.121.000300","article-title":"Nonantimicrobial actions of macrolides: Overview and perspectives for future development","volume":"73","author":"JA Kricker","year":"2021","journal-title":"Pharmacol Rev"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0358745","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T17:25:56Z","timestamp":1790270756000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0358745"}},"subtitle":[],"editor":[{"given":"Suresh Vasu","family":"Madathilparambil","sequence":"first","affiliation":[{"name":"University of Michigan","place":["UNITED STATES OF AMERICA"]}],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,9,24]]},"references-count":36,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,9,24]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0358745","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,24]]}}}